Evidence map›Paper›PMID 41440986›Full record

ArticleJournal of personalized medicine2025

The CanCURE Survey: Gender-Based Differences in HIV Cure Research Priorities.

Jessica Lu, Branka Vulesevic, Shari Margolese, Renee Masching, Wangari Tharao, Claudette Cardinal, Tanguy Hedrich, Chris Mallais, Karine Dubé, Eric Cohen and 2 more

Abstract read
In one paragraph

Article in Journal of personalized medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jessica LuFaculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.ORCID 0009-0003-6785-4131
Branka VulesevicDepartment of Medicine, Division of Infectious Diseases and Chronic Viral Illness Services, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.ORCID 0000-0003-2297-2209
Shari MargoleseCanadian HIV Cure Enterprise (CanCURE) Community Advisory Board, Toronto, ON M4P 1G8, Canada.
Renee MaschingFaculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Wangari TharaoWomen's Health in Women's Hands Community Health Centre, Toronto, ON M5B 1J3, Canada.ORCID 0000-0001-6166-401X
Claudette CardinalFaculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
Tanguy HedrichCanadian HIV Cure Enterprise (CanCURE) Community Advisory Board, Toronto, ON M4P 1G8, Canada.
Chris MallaisCanadian HIV Cure Enterprise (CanCURE) Community Advisory Board, Toronto, ON M4P 1G8, Canada.
Karine DubéDivision of Infectious Diseases and Global Public Health, University of California San Diego School of Medicine, La Jolla, CA 92093, USA.ORCID 0000-0003-3458-1539
Eric CohenInstitut de Recherche Clinique de Montréal, Montreal, QC H2W 1R7, Canada.ORCID 0000-0003-1269-3791
Nicolas ChomontDépartement de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2W 1R7, Canada.ORCID 0000-0001-9747-5018
Cecilia T CostiniukDepartment of Medicine, Division of Infectious Diseases and Chronic Viral Illness Services, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.ORCID 0000-0002-4547-714X

Funding

Canadian HIV Cure Entreprise (CanCURE 2.0 and 3.0) HB2-164064 and BR4-197730
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

community engagementgender differencesHIVHIV cure researchresearch prioritieswomen with HIV

Identifiers

PMID41440986
PMCPMC12733519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.